Cargando…
Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma
BACKGROUND: BAP1 is a histone deubiquitinase that acts as a tumor and metastasis suppressor associated with disease progression in human cancer. We have used the “Calling Card System” of transposase-directed transposon insertion mapping to identify the genomic targets of BAP1 in uveal melanoma (UM)....
Autores principales: | Yen, Matthew, Qi, Zongtai, Chen, Xuhua, Cooper, John A., Mitra, Robi D., Onken, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219186/ https://www.ncbi.nlm.nih.gov/pubmed/30400891 http://dx.doi.org/10.1186/s12920-018-0424-0 |
Ejemplares similares
-
BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
por: Matatall, Katie A, et al.
Publicado: (2013) -
Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression
por: Stålhammar, Gustav, et al.
Publicado: (2021) -
An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome
por: Young, Kelly Z., et al.
Publicado: (2020) -
Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021) -
Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma
por: Djulbegovic, Mak B., et al.
Publicado: (2022)